East Hills, NY and Fremont, CA- Pall has agreed to purchase Ciphergen Biosystems’ BioSepra Process Chromatography division for $32 million, net of cash and debt. BioSepra develops, manufactures and markets chromatography sorbents for protein purification development and biopharmaceutical manufacturing. Pall will establish Process Proteomics Service Centers modeled on Ciphergen’s existing process center. Ciphergen retains certain limited rights to access BioSepra chromatography sorbent technology for manufacture, use and sales in the research and diagnostic markets. The companies also formed an alliance to develop and promote Ciphergen’s ProteinChip Technology for use with BioSepra products for transition from research to production. The acquisition is expected to close within 45 days.